Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This update does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:06.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the earlier notice about government funding status (v3.4.1) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:50:52.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a public notice about potential disruptions due to a lapse in government funding and the NIH Clinical Center's operating status, with a link to opm.gov. Updated the site revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:34:53.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    This update adds a Show glossary option and updates footer/QC-related labels (including a new Revision: v3.4.0) and related wording, while removing the older QC-label phrasing and No FEAR Act data wording. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:54:48.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4—a minor backend change with no impact on study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:01:22.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The study locations section is updated to include Indiana, Missouri, New Mexico, Ohio, Pennsylvania, and Virginia with a revision tag v3.3.3. The previous location listings and the HHS Vulnerability Disclosure link from the prior revision (v3.3.2) were removed.
    Difference
    0.6%
    Check dated 2025-12-23T17:17:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.